Gainers
- Tenon Medical (NASDAQ:TNON) stock moved upwards by 7.7% to $1.19 during Monday's after-market session. The company's market cap stands at $13.3 million.
- Sorrento Therapeutics (NASDAQ:SRNE) stock moved upwards by 7.15% to $0.28. At the close, Sorrento Therapeutics's trading volume reached 26.7 million shares. This is 234.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $150.9 million.
- T2 Biosystems (NASDAQ:TTOO) shares moved upwards by 7.14% to $1.5. This security traded at a volume of 2.5 million shares come close, making up 1438.1% of its average volume over the last 100 days. The company's market cap stands at $10.9 million.
- Benitec Biopharma (NASDAQ:BNTC) shares rose 6.34% to $0.27. Trading volume for this security closed at 1.2 million, accounting for 310.4% of its average full-day volume over the last 100 days. The company's market cap stands at $7.5 million. The company's, Q2 earnings came out today.
- electroCore (NASDAQ:ECOR) shares moved upwards by 5.89% to $0.37. The market value of their outstanding shares is at $26.3 million.
- OncoSec Medical (NASDAQ:ONCS) stock increased by 5.26% to $1.4. The company's market cap stands at $4.1 million.
Losers
- NeuBase Therapeutics (NASDAQ:NBSE) shares fell 5.1% to $0.37 during Monday's after-market session. NeuBase Therapeutics's trading volume hit 202.2K shares by close, accounting for 66.3% of its average volume over the last 100 days. The company's market cap stands at $12.2 million.
- Rockwell Medical (NASDAQ:RMTI) stock declined by 5.07% to $2.25. The market value of their outstanding shares is at $26.1 million.
- Humacyte (NASDAQ:HUMA) stock declined by 4.99% to $2.86. The company's market cap stands at $294.9 million.
- Adaptive Biotechnologies (NASDAQ:ADPT) shares decreased by 4.9% to $8.26. The company's market cap stands at $1.1 billion.
- Akanda (NASDAQ:AKAN) shares declined by 4.81% to $0.2. Trading volume for this security closed at 564.9K, accounting for 9.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.8 million.
- Biohaven (NYSE:BHVN) stock declined by 4.79% to $16.9. The market value of their outstanding shares is at $1.1 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BHVNBiohaven Ltd
$18.00-0.61%
BNTCBenitec Biopharma Inc
$16.17-%
ECORelectroCore Inc
$4.88-3.17%
HUMAHumacyte Inc
$1.68-0.59%
RMTIRockwell Medical Inc
$1.111.83%
TNONTenon Medical Inc
$1.22-0.81%
TTOOT2 Biosystems Inc
$0.00485-96.4%
ADPTAdaptive Biotechnologies Corp
$17.001.19%
SRNESorrento Therapeutics Inc
$0.00660-%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
